Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001714899-24-000040

Chief Medical Officer sold 4,668 shares at $19.02 ($88,785)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Ho Carole · Chief Medical Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-01-10 Sale : show line 1 in the form 10b5-1 −4,668 $19.02 $88,785 147,794 D
Open-market sales · 4,668 sh · avg $19.02 · $88,785
Loading xslF345X05/wk-form4_1705108724.xml…